Research and Markets (http://www.researchandmarkets.com/research/rg49b3/lung_cancer)
has announced the addition of GlobalData's new report "Lung Cancer
Global Clinical Trials Review, H2, 2012" to their offering.
The clinical trial report, Lung Cancer Global Clinical Trials Review,
H2, 2012" provides data on the Lung Cancer clinical trial scenario. this
report provides elemental information and data relating to the clinical
trials on Lung Cancer. It includes an overview of the trial numbers and
their recruitment status as per the site of trial conduction across the
globe. The databook offers a preliminary coverage of disease clinical
trials by their phase, trial status, prominence of the sponsors and also
provides briefing pertaining to the number of trials for the key drugs
for treating Lung Cancer. This report is built using data and
information sourced from proprietary databases, primary and secondary
research nd in-house analysis by a team of industry experts.
- Data on the number of clinical trials conducted in North America,
South and Central America, Europe, Middle-East and Africa and
Asia-pacific and top five national contributions in each, along with the
clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status,
subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Eli Lilly and Company
Bristol-Myers Squibb Company
Hoffmann-La Roche Inc.
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Boehringer Ingelheim GmbH
Clinical Trial Overview of Merck KGaA
Daiichi Sankyo Company, Limited
Zhejiang Beta Pharma Inc.
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
Massachusetts General Hospital
Vanderbilt-Ingram Cancer Center
Fox Chase Cancer Center
Samsung Medical Center
Sidney Kimmel Comprehensive Cancer Center
Case Comprehensive Cancer Center
Clinical Trial Overview of Kyoto University
For more information visit http://www.researchandmarkets.com/research/rg49b3/lung_cancer
[ Back To NFVZone's Homepage ]